Podcast Episodes
Back to SearchManaging CNS lymphoma: expert insights and updates from ICML 2025
Episode 302
In this episode of the VJHemOnc podcast, we are joined by experts Kathryn Tringale, MD, UC San Diego Health, San Diego, CA, and Nikita Dave, MD, Univ…
1 year, 2 months ago
iwMDS wrap-up: translating research into practice to optimize patient care
Episode 300
VJHemOnc recently attended the 3rd International Workshop on Myelodysplastic Syndromes & Myeloproliferative Neoplasms (iwMDS & iwMPN) 2025, held in L…
1 year, 2 months ago
iwMDS wrap-up: translating research into practice to optimize patient care
VJHemOnc recently attended the 3rd International Workshop on Myelodysplastic Syndromes & Myeloproliferative Neoplasms (iwMDS & iwMPN) 2025, held in L…
1 year, 2 months ago
Targeting mutant CALR in MPNs with antibodies & cellular therapy: the potential for disease modification
Today’s episode of the VJHemOnc podcast focuses on the targeting of mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs) – a trending…
1 year, 2 months ago
Targeting mutant CALR in MPNs with antibodies & cellular therapy: the potential for disease modification
Episode 298
Today’s episode of the VJHemOnc podcast focuses on the targeting of mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs) – a trending…
1 year, 2 months ago
Treating elderly or unfit patients with AML: current approach and future directions
This episode of the VJHemOnc podcast focuses on the treatment of elderly or unfit patients with acute myeloid leukemia (AML). Featuring experts Farha…
1 year, 3 months ago
Treating elderly or unfit patients with AML: current approach and future directions
Episode 299
This episode of the VJHemOnc podcast focuses on the treatment of elderly or unfit patients with acute myeloid leukemia (AML). Featuring experts Farha…
1 year, 3 months ago
Key HemOnc updates from ASCO 2025: myeloma, lymphoma, MPNs, & more!
VJHemOnc recently attended the 2025 ASCO Annual Meeting in Chicago, IL, where we gained insights into the latest advancements in hematologic oncology…
1 year, 3 months ago
Key HemOnc updates from ASCO 2025: myeloma, lymphoma, MPNs, & more!
Episode 297
VJHemOnc recently attended the 2025 ASCO Annual Meeting in Chicago, IL, where we gained insights into the latest advancements in hematologic oncology…
1 year, 3 months ago
CHIP & CCUS: advances in understanding and should we treat these precursor conditions?
In this episode of the VJHemOnc podcast, we explore clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significan…
1 year, 3 months ago